ClinicalTrials.gg
RecruitingNCT07696416Updated Jul 13, 2026

Investigation of the Effect of Blood Pressure on Bedsores

An observational study in Decubitus Ulcer, sponsored by Yuzuncu Yil University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-07-13.

Sponsored by Yuzuncu Yil University · Observational

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
148
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The aim of this study is to comprehensively investigate the effect of blood pressure levels on the development of bedsores (pressure ulcers) in adult patients hospitalized in the internal medicine intensive care unit.

Read the detailed description

The aim of this study is to comprehensively investigate the effect of blood pressure levels on the development of bedsores (pressure ulcers) in adult patients hospitalized in the internal medicine intensive care unit. In intensive care patients, several factors, such as prolonged immobility, decreased level of consciousness, circulatory disorders, and hemodynamic instability, increase the risk of bedsore formation. This study specifically aims to evaluate the effects of systemic blood pressure changes-such as hypotension or hypertension-on skin integrity and to determine the contribution of these effects to the development of bedsores.

02

Conditions studied

  • Decubitus Ulcer

Browse trials for

Keywords

  • Decubitus Ulcer
  • Blood pressure
  • İntensive care
03

In context

Pressure Ulcer

545 studies on the registry are indexed under Pressure Ulcer; 129 are open to participants now.

This study's planned enrollment of 148 is close to the median of 138 across 110 observational studies indexed under Pressure Ulcer.

Browse Pressure Ulcer studies →

Lead sponsor

Yuzuncu Yil University is the lead sponsor of 78 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

SBU. Van Education and Research Hospital Internal Intensive Care Unit

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients admitted to the intensive care unit,
  • Aged between 18-70 years,
  • Bedridden, immobile patients,
  • Patients who have signed the form themselves or through a close relative.

Exclusion criteria

Exclusion Criteria:

  • Patients under 18 years of age,
  • Patients who did not give their consent for the study or whose relatives did not consent, or who wanted to leave while the study was ongoing,
  • Patients who arrived with bedsores
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
148 participants (estimated)
Patient registry
No

Groups and cohorts

  • Intensive care patients

    The development and timing of bedsores in patients will be recorded. Vital signs will also be monitored.

06

What researchers measure

Primary outcomes

  1. Decubitus Ulcer

    Pressure ulcers will be assessed using the Norton Pressure Ulcer Scale Daily Rating.

    Time frame: For 10 days

Secondary outcomes

  1. Vital signs - Blood pressure measurements (SBP, DBP)

    Blood pressure measurements (SBP, DBP)

    Time frame: For 10 days

  2. Vital signs - heart rate

    heart rate will be taken.

    Time frame: For 10 days

  3. Vital signs - respiratory rate

    respiratory rate per minute will be taken.

    Time frame: For 10 days

07

Study locations

1 of 1 sites recruiting
  • SBU. Van Education and Research Hospital
    Van, 65000, Turkey (Türkiye)
    Recruiting
    • Hayrullah Şavlı · Contacthayrullahsavli@gmail.com · +905308981365
    • Yavuz Uren · Principal investigator
    • Hayrullah Şavlı · Sub investigator
    • Gülden Atan · Sub investigator
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07696416
Lead sponsor
Yuzuncu Yil University
Responsible party
Yavuz Uren (Asst.Prof., Yuzuncu Yil University) — Principal investigator
First posted
Jul 10, 2026
Start date
Jul 10, 2026
Primary completion
Nov 20, 2026 (estimated)
Completion
Nov 20, 2026 (estimated)
Last update
Jul 13, 2026

Study contacts

Hayrullah ŞAVLI
Contact
hayrullahsavli@gmail.com
+905308981365
yavuz üren
study chair · Yuzuncu Yil University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion